HA-based dermal filler: downstream process comparison, impurity quantitation by validated HPLC-MS analysis, and in vivo residence time study
Open Access
- 1 April 2019
- journal article
- research article
- Published by SAGE Publications in Journal of Applied Biomaterials & Functional Materials
- Vol. 17 (3)
Abstract
The success of hyaluronic acid (HA)-based dermal fillers, with more than 2 million minimally invasive procedures conducted in 2016 in the US alone, is due to their hygroscopic properties of biocompatibility and reversibility. The type and density of HA cross-linkage, as well as the manufacturing technology, may influence not only the in vivo persistence but also the safety profile of dermal fillers. 1,4-Butanediol diglycidyl ether (BDDE) is the cross-linker used in most market-leading HA fillers; 1,4-butanediol di-(propan-2,3-diolyl) ether (BDPE) is the major impurity obtained from the HA–BDDE cross-linking (HBC) process. In this work, a new process to obtain high purity HBC fillers was developed. A new HPLC-MS method was validated for the quantification of BDPE content in HBC dermal fillers. In vitro cytotoxicity of BDPE was evaluated in fibroblasts (IC50 = 0.48 mg/mL). The viscoelasticity was monitored during the shelf-life of the HBC-10% hydrogel and was correlated with in vitro hyaluronidase resistance and in vivo residence time in a rabbit model. This analysis showed that elasticity is the best parameter to predict the in vivo residence time. Finally, a series of parameters were investigated in certain marketed dermal fillers and were compared with the results of the HBC-10% hydrogel.Keywords
This publication has 17 references indexed in Scilit:
- Complications of hyaluronic acid fillers and their managementsJournal of Dermatology and Dermatologic Surgery, 2016
- Foreign Body Granulomas after the Use of Dermal Fillers: Pathophysiology, Clinical Appearance, Histologic Features, and TreatmentArchives of Plastic Surgery, 2015
- Injectable Fillers: Review of Material and PropertiesFacial Plastic Surgery, 2015
- A Review of the Metabolism of 1,4-Butanediol Diglycidyl Ether-Crosslinked Hyaluronic Acid Dermal FillersDermatologic Surgery, 2013
- SEC determination of cross-link efficiency in hyaluronan fillersCarbohydrate Polymers, 2012
- Hyaluronic Acid Fillers: A Comprehensive ReviewFacial Plastic Surgery, 2009
- Hyaluronic acid gel (Juvéderm™) preparations in the treatment of facial wrinkles and foldsClinical Interventions in Aging, 2008
- Crosslinked hyaluronic acid dermal fillers: A comparison of rheological propertiesJournal of Biomedical Materials Research Part A, 2008
- Review of long-term adverse effects associated with the use of chemically-modified animal and nonanimal source hyaluronic acid dermal fillersClinical Interventions in Aging, 2008
- Cross-Linked Hyaluronic Acid FillersPlastic and Reconstructive Surgery, 2006